A Clinical trial to study the effect of the drug Atropine in patients with myopia to slow down its progression.
Not Applicable
- Conditions
- Health Condition 1: H521- Myopia
- Registration Number
- CTRI/2022/09/045977
- Lead Sponsor
- Comtrust Charitable trust Eye Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Open to Recruitment
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Myopic patients of 6â??13 year age group, Refractive error of -1.0 D to -6.0 D, Associated astigmatism of -1.5 D or less, Documented myopic progression of at least 0.5 D in the past year
Exclusion Criteria
Any other additional eye pathology other than myopia, Previous use of Atropine Eye drops, an allergy to atropine, or systemic ill health (e.g., cardiac or respiratory illness)
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method